Anti-Inflammatory Interleukin 10 Inversely Relates to Coronary Atherosclerosis in Persons With Human Immunodeficiency Virus

J Infect Dis. 2020 Feb 3;221(4):510-515. doi: 10.1093/infdis/jiz254.

Abstract

Interleukin 10 (IL-10) is an anti-inflammatory cytokine that may be protective against coronary atherosclerosis. In an observational study of persons with human immunodeficiency virus (PWH) and uninfected controls, IL-10 was measured in serum samples by means of enzyme-linked immunosorbent assay, and coronary atherosclerosis was assessed using computed tomographic angiography. Among PWH, a 10-fold decrease in IL-10 was associated with a 2.6-fold increase in the odds of coronary plaque (P = .01), after controlling for traditional and nontraditional cardiovascular risk factors. IL-10 was also inversely associated with total coronary plaque (ρ = -0.19; P = .02) and noncalcified coronary plaque (ρ = -0.24; P = .004). Our findings suggest a role for IL-10 in mitigating atherosclerosis in PWH. Clinical Trials Registration. NCT00455793.

Keywords: HIV; IL-10; Inflammation; atherosclerosis.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Biomarkers / blood
  • Computed Tomography Angiography
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / complications*
  • Coronary Artery Disease / diagnostic imaging
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV-1 / genetics*
  • Humans
  • Inflammation / blood
  • Inflammation / immunology
  • Interleukin-10 / blood*
  • Interleukin-10 / immunology
  • Male
  • Middle Aged
  • Plaque, Atherosclerotic / diagnostic imaging
  • RNA, Viral / genetics
  • Risk Factors

Substances

  • Anti-HIV Agents
  • Biomarkers
  • IL10 protein, human
  • RNA, Viral
  • Interleukin-10

Associated data

  • ClinicalTrials.gov/NCT00455793